Literature DB >> 28257537

Primary Ovarian Insufficiency: Current Concepts.

Gretchen Collins1, Bansari Patel1, Suruchi Thakore1, James Liu1.   

Abstract

A potential consequence of chemotherapy is the destruction of oocytes, resulting in primary ovarian insufficiency (POI) in young patients; this often results in secondary amenorrhea and necessitates hormone replacement therapy. Regardless of the etiology of POI, the chance of pregnancy is low in this patient population. Given the extent to which oocyte depletion or dysfunction is variable, there is the possibility of spontaneous ovulation on hormone replacement therapy and subsequent pregnancy, however. If pregnancy is not desired, contraception always should be discussed. In most patients, the etiology of POI will not be known, but the treatment for all patients includes estrogen and progesterone therapy, which ensures the development of secondary sex characteristics, acquisition of peak bone mass, and promotion of uterine growth and maturation. Early diagnosis, patient education, and emotional support are important to mitigate long-term sequelae.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28257537     DOI: 10.14423/SMJ.0000000000000611

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

Review 1.  Mechanisms of ovarian aging.

Authors:  Selena U Park; Leann Walsh; Karen M Berkowitz
Journal:  Reproduction       Date:  2021-07-14       Impact factor: 3.923

2.  Transcriptomic landscape of granulosa cells and peripheral blood mononuclear cells in women with PCOS compared to young poor responders and women with normal response.

Authors:  Mauro Cozzolino; Sonia Herraiz; Shiny Titus; Leah Roberts; Monica Romeu; Irene Peinado; Richard T Scott; Antonio Pellicer; Emre Seli
Journal:  Hum Reprod       Date:  2022-05-30       Impact factor: 6.353

Review 3.  Long non-coding RNAs in ovarian granulosa cells.

Authors:  Jiajie Tu; Yu Chen; Zhe Li; Huan Yang; He Chen; Zhiying Yu
Journal:  J Ovarian Res       Date:  2020-06-05       Impact factor: 4.234

4.  Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice.

Authors:  Ziling Yang; Xin Du; Cunli Wang; Jin Zhang; Conghui Liu; Yu Li; Hong Jiang
Journal:  Stem Cell Res Ther       Date:  2019-08-14       Impact factor: 6.832

5.  Heterozygous FMN2 missense variant found in a family case of premature ovarian insufficiency.

Authors:  Jie Li; Tianliu Peng; Le Wang; Panpan Long; Ruping Quan; Hangjing Tan; Minghua Zeng; Xue Wu; Junting Yang; Hongmei Xiao; Xiaobo Shi
Journal:  J Ovarian Res       Date:  2022-02-28       Impact factor: 4.234

Review 6.  Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge.

Authors:  Anna Szeliga; Anna Calik-Ksepka; Marzena Maciejewska-Jeske; Monika Grymowicz; Katarzyna Smolarczyk; Anna Kostrzak; Roman Smolarczyk; Ewa Rudnicka; Blazej Meczekalski
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

7.  Long non-coding RNA Xist regulates oocyte loss via suppressing miR-23b-3p/miR-29a-3p maturation and upregulating STX17 in perinatal mouse ovaries.

Authors:  Meng Zhou; Xiaoqiu Liu; E Qiukai; Yanxing Shang; Xiaoqian Zhang; Shuting Liu; Xuesen Zhang
Journal:  Cell Death Dis       Date:  2021-05-25       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.